Blinding in clinical trials is a methodological practice used to prevent bias by concealing the allocation of participants to different intervention groups from researchers, participants, or both. This ensures that the outcomes are not influenced by preconceived expectations or placebo effects, thus maintaining the integrity and credibility of the trial results.